ODTC

ODONATE INC by Odonate, Inc. (ODTC)

About ODONATE INC by Odonate, Inc. (ODTC)

Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.

Details

Daily high
$150,000.00
Daily low
$150,000.00
Price at open
$50,000.00
52 Week High
$176,040.00
52 Week Low
$22,005.00
Market cap
54,848
Dividend yield
0.00%
Volume
1
Avg. volume
0
P/E ratio
--

ODONATE INC by Odonate, Inc. News

Details

Daily high
$150,000.00
Daily low
$150,000.00
Price at open
$50,000.00
52 Week High
$176,040.00
52 Week Low
$22,005.00
Market cap
54,848
Dividend yield
0.00%
Volume
1
Avg. volume
0
P/E ratio
--